EcoDrugPlus

Somatostatin Receptor 1

Ensembl ID : ENSEEEG00000004331
Gene Symbol: SSTR1
4 Cross references
160 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSEEEG00000001461
Gene Symbol: SSTR2
4 Cross references
192 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSEEEG00000002766
Gene Symbol: SSTR2
1 Cross references
192 Possible Orthologues:

Somatostatin Receptor 3

Ensembl ID : ENSEEEG00000019942
Gene Symbol: SSTR3
3 Cross references
187 Possible Orthologues:

Somatostatin Receptor Type 5

Ensembl ID : ENSEEEG00000004601
Gene Symbol: LOC113580352
3 Cross references
184 Possible Orthologues:

Sphingosine Kinase 2

Ensembl ID : ENSEEEG00000024011
Gene Symbol: SPHK2
3 Cross references
202 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSEEEG00000015352
Gene Symbol: S1PR1
4 Cross references
193 Possible Orthologues:

Spleen Tyrosine Kinase

Ensembl ID : ENSEEEG00000019803
Gene Symbol: SYK
4 Cross references
203 Possible Orthologues:

Steroid 17-Alpha-Hydroxylase/17,20 Lyase

Ensembl ID : ENSEEEG00000000866
Gene Symbol: LOC113585465
4 Cross references
211 Possible Orthologues:

Steroid-5-Alpha-Reductase, Alpha Polypeptide 2a

Ensembl ID : ENSEEEG00000017437
Gene Symbol: SRD5A2A
4 Cross references
208 Possible Orthologues:

Synuclein Alpha

Ensembl ID : ENSEEEG00000000544
Gene Symbol: SNCA
2 Cross references
189 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSEEEG00000014535
Gene Symbol: TACR1
2 Cross references
215 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).